Status:
COMPLETED
Safety and Efficacy of Olopatadine Hydrochloride/Ketorolac Tromethamine Ophthalmic Solution Compared With Olopatadine Hydrochloride Ophthalmic Solution in Patients With Seasonal Allergic Conjunctivitis
Lead Sponsor:
Allergan
Conditions:
Rhinitis, Allergic, Seasonal
Conjunctivitis, Allergic
Eligibility:
All Genders
18+ years
Phase:
PHASE3
Brief Summary
This study will investigate the safety and efficacy of olopatadine hydrochloride / ketorolac tromethamine fixed dose combination ophthalmic solution compared with olopatadine hydrochloride ophthalmic ...
Eligibility Criteria
Inclusion
- Clinical diagnosis of seasonal allergic conjunctivitis
Exclusion
- Ocular infection or history of ocular herpes infection
- History of retinal detachment or diabetic retinopathy
- Prior or current use of systemic or topical steroids, NSAIDs, anticholinergics, immunosuppressants, or antihistamines
- Ocular surgery within 8 weeks
Key Trial Info
Start Date :
December 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 1 2011
Estimated Enrollment :
129 Patients enrolled
Trial Details
Trial ID
NCT01258309
Start Date
December 1 2010
End Date
January 1 2011
Last Update
January 25 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Bangalore, Karnataka, India